Find a Commonwealth Resource
Patent AT-E400274-T1: [Translated] ACT ACTIVITY INHIBITORS
HealthData.Gov
Updated Oct 29, 2026
About this dataset
The present invention is directed to compounds comprising a 2,3-diphenylquinoxaline moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention
Data and resources (1)
- HTML
Official Data Source
Access the complete Patent AT-E400274-T1: [Translated] ACT ACTIVITY INHIBITORS on the official website.
Modified Apr 29, 2026